CDH2 and meningioma: Therefore, we can speculate that CDH1 and CDH2 genes may represent a useful prognostic marker of meningioma progression, especially since genetic changes occur in benign stages and increase their frequency by transitioning to malignant forms (especially LOH in the CDH2 gene).